Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-25-000019

Chief Financial Officer acquired 11,134 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
WENTWORTH KORY JAMES Chief Financial Officer 2025-04-03 Option exercise +11,134 $2.10 $23,381 120,670 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
WENTWORTH KORY JAMES Chief Financial Officer 2025-04-03 Option exercise · Stock Option (Right to Buy) −11,134 20,023 D: show line 2 in the form
Loading xslF345X05/wk-form4_1743798826.xml…